Aclaris Therapeutics (ACRS) Other Gross PP&E Adjustments (2014 - 2025)
Aclaris Therapeutics' quarterly Other Gross PP&E Adjustments came in at -$20.1 million in Q4 2025, down 51.21% year-on-year from -$41.2 million in Q4 2024, and down 446.73% quarter-over-quarter from $5.8 million in Q3 2025.
Aclaris Therapeutics has reported Other Gross PP&E Adjustments for 12 years, with the latest figure at -$20.1 million in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 51.21% year-over-year to -$20.1 million; the trailing twelve-month figure through Mar 2026 stood at -$20.1 million (down 443.12% YoY), and the FY2025 full-year result was -$20.1 million, down 51.21% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$20.1 million, down from $5.8 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $6.3 million in Q3 2023, with the low at -$20.1 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is $396600.0, with a median of $5.0 million recorded in 2022.
- Year-over-year, Other Gross PP&E Adjustments grew 27.18% in 2023 and tumbled 51.21% in 2025.
- Tracing ACRS's Other Gross PP&E Adjustments over 5 years: stood at -$13.0 million in 2021, then decreased by 9.98% to -$14.3 million in 2022, then advanced by 14.16% to -$12.3 million in 2023, then declined by 8.27% to -$13.3 million in 2024, then plunged by 51.21% to -$20.1 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$20.1 million (Q4 2025), $5.8 million (Q3 2025), and $5.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Aclaris Therapeutics | 586.09 Mn | 586.09 Mn | 1.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.09 Mn |
| Dec 31, 2025 | -20.09 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Dec 31, 2024 | -13.29 Mn |
| Dec 31, 2024 | -13.29 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 5.87 Mn |
| Mar 31, 2024 | 5.87 Mn |
| Dec 31, 2023 | -12.27 Mn |
| Dec 31, 2023 | -12.27 Mn |
| Sep 30, 2023 | 6.35 Mn |
| Sep 30, 2023 | 6.35 Mn |
| Jun 30, 2023 | 6.27 Mn |
| Jun 30, 2023 | 6.27 Mn |
| Mar 31, 2023 | 5.67 Mn |
| Mar 31, 2023 | 5.67 Mn |
| Dec 31, 2022 | -14.30 Mn |
| Dec 31, 2022 | -14.30 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 4.94 Mn |
| Jun 30, 2022 | 4.94 Mn |
| Mar 31, 2022 | 4.76 Mn |
| Mar 31, 2022 | 4.76 Mn |
| Dec 31, 2021 | -13.00 Mn |
| Dec 31, 2021 | -13.00 Mn |
| Sep 30, 2021 | 4.37 Mn |
| Sep 30, 2021 | 4.37 Mn |
| Jun 30, 2021 | 4.29 Mn |
| Jun 30, 2021 | 4.29 Mn |
| Mar 31, 2021 | 4.22 Mn |
| Mar 31, 2021 | 4.22 Mn |
| Dec 31, 2020 | -10.25 Mn |
| Dec 31, 2020 | -10.25 Mn |
| Sep 30, 2020 | 4.40 Mn |
| Sep 30, 2020 | 4.40 Mn |
| Jun 30, 2020 | 4.34 Mn |
| Jun 30, 2020 | 4.34 Mn |
| Mar 31, 2020 | 3.95 Mn |
| Mar 31, 2020 | 3.95 Mn |
| Dec 31, 2019 | -8.87 Mn |
| Dec 31, 2019 | -8.87 Mn |
| Sep 30, 2019 | 4.30 Mn |
| Sep 30, 2019 | 4.30 Mn |
| Jun 30, 2019 | 789,000.00 |
| Jun 30, 2019 | 789,000.00 |
| Mar 31, 2019 | -1.50 Mn |
| Mar 31, 2019 | -1.50 Mn |
| Dec 31, 2018 | -5.43 Mn |
| Dec 31, 2018 | -5.43 Mn |
| Sep 30, 2018 | 5.42 Mn |
| Sep 30, 2018 | 5.42 Mn |
| Jun 30, 2018 | 4.97 Mn |
| Jun 30, 2018 | 4.97 Mn |
| Mar 31, 2018 | 2.87 Mn |
| Mar 31, 2018 | 2.87 Mn |
| Dec 31, 2017 | -3.58 Mn |
| Dec 31, 2017 | -3.58 Mn |
| Sep 30, 2017 | 1.53 Mn |
| Sep 30, 2017 | 1.53 Mn |
| Jun 30, 2017 | 1.07 Mn |
| Jun 30, 2017 | 1.07 Mn |
| Mar 31, 2017 | 773,000.00 |
| Mar 31, 2017 | 773,000.00 |
| Dec 31, 2016 | -2.02 Mn |
| Dec 31, 2016 | -2.02 Mn |
| Sep 30, 2016 | 546,000.00 |
| Sep 30, 2016 | 546,000.00 |
| Jun 30, 2016 | 426,000.00 |
| Jun 30, 2016 | 426,000.00 |
| Mar 31, 2016 | 199,000.00 |
| Mar 31, 2016 | 199,000.00 |
| Dec 31, 2015 | 29,000.00 |
| Dec 31, 2015 | 29,000.00 |
| Sep 30, 2015 | 845,000.00 |
| Sep 30, 2015 | 845,000.00 |
| Dec 31, 2014 | 542,000.00 |
| Dec 31, 2014 | 542,000.00 |